MarketPeel
Insider Trading Intelligence
Pricing
…
VL

Viking Global Opportunities Parent Gp Llc

APG
10% OWNER · API GROUP CORP · CIK 0001886738
FILING MIX · LIFETIME16%/84%
BUYS
9
SELLS
46
TOTAL VALUE
$1.63B
COMPANIES
9
ACTIVE SINCE
Jan 2022
HOLDINGS NOW
315,142,910
AVG SELL PX
$27.32
TRADE KIND
SHOWING 55 / 55
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
28 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Viking Global Opportunities Parent Gp Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d28+46.43%+4.58%-1.88%+6.46%+3.25%—
14d28+28.57%+2.76%-4.07%+6.83%+5.63%—
30d28+17.86%+26.29%-5.67%+31.96%+25.41%—
60d28+17.86%+33.12%-3.10%+36.22%+26.06%—
90d28+7.14%+34.61%-1.34%+35.95%+34.19%—
180d28+3.57%+32.22%+0.24%+31.98%+32.55%—
1y28(3 pending)+88.00%-10.71%+11.68%-22.39%-37.18%—
2y28(5 pending)+73.91%-68.24%+36.92%-105.16%-130.06%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
APG · 0 shares · as of Jun 17, 2024
06,758,12913,516,25820,274,38727,032,516SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 9 buys / 46 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INBX
INHIBRX BIOSCIENCES, INC.
SALE
308,643$32.25$9.95M1,267,823Oct 7, 2025Oct 9, 2025 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
SALE
25,042$32.25$807.6K102,864Oct 7, 2025Oct 9, 2025 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
SALE
16,315$32.25$526.2K67,018Oct 7, 2025Oct 9, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
3,500,000$44.00$154.00M18,555,375Jun 27, 2025Jul 1, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
3,065,616$34.90$106.99M22,055,375Jan 31, 2025Jan 31, 2025 ↗View →
APG
API GROUP CORP
SALE
39,032$38.15$1.49M0Jun 17, 2024Jun 18, 2024 ↗View →
APG
API GROUP CORP
SALE
1,912,750$38.15$72.97M0Jun 17, 2024Jun 18, 2024 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
SALE
6,305,866$30.00$189.18M0May 30, 2024Jun 3, 2024 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
SALE
1,038,765$30.00$31.16M0May 30, 2024Jun 3, 2024 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
SALE
333,333$30.00$10.00M0May 30, 2024Jun 3, 2024 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
SALE
511,627$30.00$15.35M0May 30, 2024Jun 3, 2024 ↗View →
APG
API GROUP CORP
SALE
60,772$34.25$2.08M39,032Mar 5, 2024Mar 7, 2024 ↗View →
APG
API GROUP CORP
SALE
2,977,845$34.25$101.99M1,912,750Mar 5, 2024Mar 7, 2024 ↗View →
APG
API GROUP CORP
SALE
81,300$36.90$3.00M99,804Feb 28, 2024Mar 1, 2024 ↗View →
APG
API GROUP CORP
PURCHASE
8,036,862$24.60$197.71M8,874,334Feb 28, 2024Mar 1, 2024 ↗View →
APG
API GROUP CORP
SALE
3,983,739$36.90$147.00M4,890,595Feb 28, 2024Mar 1, 2024 ↗View →
APG
API GROUP CORP
SALE
196,000——0Feb 28, 2024Mar 1, 2024 ↗View →
APG
API GROUP CORP
PURCHASE
164,016$24.60$4.03M181,104Feb 28, 2024Mar 1, 2024 ↗View →
APG
API GROUP CORP
SALE
4,000——0Feb 28, 2024Mar 1, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
540,000$19.53$10.55M4,247,914Jan 4, 2024Jan 5, 2024 ↗View →
APG
API GROUP CORP
SALE
3,983$31.30$124.7K17,088Jan 2, 2024Jan 4, 2024 ↗View →
APG
API GROUP CORP
SALE
195,200$31.30$6.11M837,472Jan 2, 2024Jan 4, 2024 ↗View →
APG
API GROUP CORP
SALE
6,300,817$31.30$197.22M27,032,516Jan 2, 2024Jan 4, 2024 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
PURCHASE
1,038,765$19.35$20.10M1,038,765Aug 28, 2023Aug 30, 2023 ↗View →
INBX
INHIBRX BIOSCIENCES, INC.
PURCHASE
511,627$19.35$9.90M511,627Aug 28, 2023Aug 30, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
1,500,000$35.00$52.50M25,120,991Jul 18, 2023Jul 19, 2023 ↗View →
ROIV
ROIVANT SCIENCES LTD.
SALE
5,427,043$9.90$53.73M31,409,512Jun 22, 2023Jun 26, 2023 ↗View →
ROIV
ROIVANT SCIENCES LTD.
SALE
2,226,195$9.90$22.04M12,884,307Jun 22, 2023Jun 26, 2023 ↗View →
ROIV
ROIVANT SCIENCES LTD.
SALE
5,236,006$9.90$51.84M30,303,871Jun 22, 2023Jun 26, 2023 ↗View →
ROIV
ROIVANT SCIENCES LTD.
SALE
110,756$9.90$1.10M641,010Jun 22, 2023Jun 26, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
850,000$16.00$13.60M4,787,914May 9, 2023May 11, 2023 ↗View →
RLYB
RALLYBIO CORP
PURCHASE
3,333,388$6.00$20.00M3,333,388Nov 15, 2022Nov 17, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
4,870,536——0Nov 11, 2022Jan 13, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
3,142$31.44$98.8K1,850,940Sep 9, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
147,502$29.87$4.41M1,927,968Sep 9, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
6,654$31.44$209.2K3,919,596Sep 9, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
73,886$30.90$2.28M1,854,082Sep 9, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
312,353$29.87$9.33M4,082,713Sep 9, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
156,463$30.90$4.83M3,926,250Sep 9, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
111,102$32.23$3.58M4,395,066Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
7,554$30.59$231.1K2,127,936Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
108,631$28.16$3.06M4,681,190Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
38,116$27.28$1.04M2,261,884Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
159,026$29.14$4.63M4,522,164Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
15,996$30.59$489.3K4,506,168Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
52,466$32.23$1.69M2,075,470Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
51,298$28.16$1.44M2,210,586Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
75,096$29.14$2.19M2,135,490Sep 8, 2022Sep 9, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
SALE
80,715$27.28$2.20M4,789,821Sep 8, 2022Sep 9, 2022 ↗View →
PRCT
PROCEPT BIOROBOTICS CORP
SALE
1,147,205$29.90$34.30M3,360,687Mar 18, 2022Mar 22, 2022 ↗View →
PRCT
PROCEPT BIOROBOTICS CORP
SALE
101,795$29.90$3.04M298,205Mar 18, 2022Mar 22, 2022 ↗View →
DNA
GINKGO BIOWORKS HOLDINGS, INC.
SALE
288,000,000——51,055,144Mar 2, 2022Mar 4, 2022 ↗View →
DNA
GINKGO BIOWORKS HOLDINGS, INC.
PURCHASE
288,000,000——288,000,000Mar 2, 2022Mar 4, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
4,870,536——4,870,536Jan 11, 2022Jan 13, 2022 ↗View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
2,300,000$19.00$43.70M2,300,000Jan 11, 2022Jan 13, 2022 ↗View →
Other insiders · APG
Loading peer insiders…
About this filer
CIK 0001886738
ROLE
10% Owner
PRIMARY
APG
COMPANIES
9
ACTIVE SINCE
Jan 2022
MARKETPEEL · /INSIDER/0001886738DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback